Suppression of RANKL-dependent heme oxygenase-1 is required for high mobility group box 1 release and osteoclastogenesis.
about
HMGB1 in health and disease.Effects of light-emitting diode irradiation on RANKL-induced osteoclastogenesis.Therapeutic effects of intrabone and systemic mesenchymal stem cell cytotherapy on myeloma bone disease and tumor growthMolecular regulatory mechanisms of osteoclastogenesis through cytoprotective enzymes.Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1.Role of heme oxygenase-1 in postnatal differentiation of stem cells: a possible cross-talk with microRNAs.Rab27A regulates transport of cell surface receptors modulating multinucleation and lysosome-related organelles in osteoclasts.High-mobility group box 1 (HMGB1) in childhood: from bench to bedside.Rab44, a novel large Rab GTPase, negatively regulates osteoclast differentiation by modulating intracellular calcium levels followed by NFATc1 activation.Dual Effects of Liquiritigenin on the Proliferation of Bone Cells: Promotion of Osteoblast Differentiation and Inhibition of Osteoclast Differentiation.Treatment with hydrogen molecules prevents RANKL-induced osteoclast differentiation associated with inhibition of ROS formation and inactivation of MAPK, AKT and NF-kappa B pathways in murine RAW264.7 cells.Inhibitory effects of tert-butylhydroquinone on osteoclast differentiation via up-regulation of heme oxygenase-1 and down-regulation of HMGB1 release and NFATc1 expression.tBHQ Suppresses Osteoclastic Resorption in Xenogeneic-Treated Dentin Matrix-Based Scaffolds.Cobalt protoporphyrin represses osteoclastogenesis through blocking multiple signaling pathways.Castalagin Exerts Inhibitory Effects on Osteoclastogenesis Through Blocking a Broad Range of Signaling Pathways with Low Cytotoxicity.
P2860
Q34622835-4373AB5C-6E37-45D4-8C5D-6776EAD6885CQ35782612-F267F17F-35A5-4CE2-B58B-9D0ACB38672CQ36092153-901EE35D-1FC2-489F-89D3-6AA720B0BCC1Q36517710-D941944E-208D-4717-A245-248A94449859Q37465978-44BDB391-95A9-4333-949C-BDF835832EBDQ37653706-9ABB9648-BFFB-471E-AF82-2C673B414B1BQ37738764-AEE1272F-4F11-4595-AB68-37EB2AD89CA4Q38210271-118C4EEE-7CD5-4412-A803-EF15E68138A5Q38695357-0AAB56E4-2ECE-499A-A3C4-07D8275245B3Q38853262-D5C0826F-F053-4232-883A-C8246E76F1AFQ39066528-05C35ACB-CA03-460C-A942-100479EB02DAQ39251233-D7A1ADF7-DF29-4735-8D85-4A0C53A3FD2AQ47937699-6B51DD09-17DB-4208-92B9-5973CB1CB73DQ52942810-7CAF4E03-614C-4E9A-8FBC-C2A6248491B6Q52956230-A2BA1E46-04AC-47D4-9A46-BCDC8DE3526A
P2860
Suppression of RANKL-dependent heme oxygenase-1 is required for high mobility group box 1 release and osteoclastogenesis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Suppression of RANKL-dependent ...... elease and osteoclastogenesis.
@en
Suppression of RANKL-dependent ...... elease and osteoclastogenesis.
@nl
type
label
Suppression of RANKL-dependent ...... elease and osteoclastogenesis.
@en
Suppression of RANKL-dependent ...... elease and osteoclastogenesis.
@nl
prefLabel
Suppression of RANKL-dependent ...... elease and osteoclastogenesis.
@en
Suppression of RANKL-dependent ...... elease and osteoclastogenesis.
@nl
P2093
P2860
P356
P1476
Suppression of RANKL-dependent ...... elease and osteoclastogenesis.
@en
P2093
Eiko Sakai
Kazuhisa Nishishita
Koji Nakayama
Kuniaki Okamoto
Mariko Naito
Megumi Shimada-Sugawara
Takayuki Tsukuba
Yutaka Fukuma
P2860
P304
P356
10.1002/JCB.23372
P577
2012-02-01T00:00:00Z